Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study

Fig. 3

Number of classes of anti-hypertensive medications at baseline for MM and non-MM patients. Anti-hypertensive medications by class included diuretics, ACE-I, angiotensin II blockers, calcium channel blockers and others (alpha blockers, alpha-2 receptor agonists, beta-blockers, central agonists, combined alpha and beta blockers, peripheral adrenergic inhibitors, renin inhibitors and vasodilators). ACE-I, angiotension-converting enzyme inhibitor; MM, multiple myeloma

Back to article page